Microsimulation model for evaluating the effect of cancer control program: example for colorectal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Microsimulation model for evaluating the effect of cancer control program: example for colorectal cancer

Published:2021 Issue:2 Volume:41 Page:93-115
ISSN:0918-4430
Container-title:Japanese Journal of Biometrics
language:en
Short-container-title:Jpn J Biomet

Author:

Kamo Ken-ichi¹,Fukui Keisuke²³,Sakamoto Wataru⁴,Ito Yuri³

Affiliation:

1. Center for Medical Education, Sapporo Medical University

2. Graduate School of Advanced Science and Engineering, Hiroshima University

3. Research & Development Center, Osaka Medical College

4. Graduate School of Environmental and Life Science, Okayama University

Publisher

The Biometric Society of Japan

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jjb/41/2/41_93/_pdf

Reference44 articles.

1. Arrospide, A., Idigoras, I., Mar, J., de Koning, H., van der Meulen, M., Soto-Gordoa, M., et al.（2018）Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model. BMC cancer, 18, 464.

2. Brenner, H., Altenhofen, L., Katalinic, A., Lansdorp-Vogelaar, I. and Hoffmeister, M.（2011）Sojourn time of preclinical colorectal cancer by sex and age：estimates from the German national screening colonoscopy database. American journal of epidemiology, 174, 1140-1146.

3. Cancer, C. P. A.（2018）OncoSim - Answer complex questions to improve patient outcomes and optimize cancer system resources.，2018.

4. Criss, S. D., Mooradian, M. J., Sheehan, D. F., Zubiri, L., Lumish, M. A., Gainor, J. F., et al. (2018) Cost-effectiveness and Budgetary Consequence Analysis of Durvalumab Consolidation Therapy vs No Consolidation Therapy After Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer in the Context of the US Health Care System. JAMA Oncol.

5. Criss, S. D., Weaver, D. T., Sheehan, D. F., Lee, R. J., Pandharipande, P. V and Kong, C. Y.（2019）Effect of PD-L1 testing on the cost-effectiveness and budget impact of pembrolizumab for advanced urothelial carcinoma of the bladder in the United States. Urol Oncol, 37, 180.e11--180.e18.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3